Background:
Transdermal delivery is an alternative route for the administration of drugs.
However, it requires the development of vehicles that allow the drugs to cross the layers of the skin and
reach the systemic circulation.
Objective:
In this study, a new transdermal vehicle was evaluated using progesterone, estradiol, estradiol
+ estriol (Biest) and ketoprofen administered as model drugs.
</P><P>
Methods: To evaluate the ex vivo permeation of the drugs, the Franz vertical diffusion cell with human
skin was used.
Results:
After 24 h, the vehicle was able to deliver 18.32 µg/cm2 of progesterone and 92.07 µg/cm2 of
ketoprofen through the skin to the receptor medium. The permeation percentages were 91%, 78.8%,
48.5%, 73.2%, and 63.6%, respectively, for estradiol, estradiol (Biest), estriol (Biest), progesterone and
ketoprofen. For all drugs, sufficient amounts were delivered to achieve a systemic effect, and it was
also possible to decrease the amount of emulsion applied.
Thus, the vehicle demonstrated a high performance and the possibility of it being used for
drugs that present difficulties in regards to administration by the transdermal route.
Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation